UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2024
Commission file number: 001-42004
NEWGENIVF GROUP LIMITED
36/39-36/40, 13th Floor, PS Tower
Sukhumvit 21 Road (Asoke)
Khlong Toei Nuea Sub-district
Watthana District, Bangkok 10110
Thailand
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20- F ☒ Form 40-F ☐
EXPLANATORY NOTE
On August 28, 2024, NewGenIvf Group Limited (“Company”) consummated the second tranche of its debt financing under the terms of the Securities Purchase Agreement referenced in the current report on Form 6-K filed with the United States Securities and Exchange Commission (the “SEC”) on August 16, 2024. The Form 6-K filed with the SEC on August 16, 2024 is incorporated by reference herein. At the closing of the second tranche, the Company sold to JAK Opportunities VI LLC (“JAK”) a senior convertible note (the “Note”) in the principal amount of $500,000. The Note bears an interest rate of 14.75% per annum and may be adjustable from time to time pursuant to its terms. The holder of the Note may convert any portion of the outstanding and unpaid Conversion Amount (as defined below) into validly issued, fully paid and non-assessable Class A Shares at the Conversion Rate (as defined below). No fractional Class A Shares are issuable upon any such conversion. If the issuance would result in the issuance of a fraction of a Class A Share, the Company shall round such fraction of a Class A Share up to the nearest whole share. The maximum number of Class A Ordinary Shares of the Company, no par value, which this note is issuable into is 875,658, based on a conversion price of $0.95. The form of the Note is filed as Exhibit 4.1 hereto.
“Conversion Amount” means 110% of the sum of (A) the portion of the principal of the Note, (B) accrued and unpaid interest with respect to such principal owed on the Note (and as reduced pursuant to the of the Note pursuant to redemption, conversion or otherwise, the “Principal”) (C) the Make-Whole Amount, if any, (D) accrued and unpaid Late Charges (as defined below) with respect to the Principal on the Note, Make-Whole Amount and Interest, and (E) any other unpaid amounts pursuant to the Transaction Documents, as may be amended from time to time., if any.
“Conversion Rate” means the amount of Class A Shares issuable upon conversion of any Conversion Amount pursuant to the Note determined by dividing (x) such Conversion Amount by (y) the Conversion Price.
“Conversion Price” means, as of any Conversion Date or other date of determination, $0.83, subject to adjustment as provided in the Note.
“Late Charge” means a late charge incurred and payable by the Company in an amount equal to interest on such amount at the rate of eighteen percent (18%) per annum from the date such amount was due until the same is paid in full, if “Make-Whole Amount” means, as of any given date and as applicable, in connection with any conversion, redemption or other repayment hereunder, an amount equal to the amount of additional interest that would accrue under the Note at the interest rate then in effect assuming for calculation purposes that the outstanding Principal of the Note as of the closing date remained outstanding through and including the maturity date.
“Make-Whole Amount” means, as of any given date and as applicable, in connection with any conversion, redemption or other repayment under the Note, an amount equal to the amount of additional interest that would accrue under the Note at the interest rate then in effect assuming for calculation purposes that the outstanding Principal of the Note as of the Closing Date remained outstanding through and including the maturity date.
The foregoing is only a brief description of the Note and such description is qualified in its entirety by reference to the full text of the Note, filed as Exhibit 4.1 in this current report on Form 6-K.
EXHIBITS
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | NewGenIvf Group Limited |
| | | |
| | By: | /s/ Wing Fung Alfred Siu |
| | Name: | Wing Fung Alfred Siu |
| | Title: | Chairman of the Board and Director |
Date: August 30, 2024
3
